KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $653,000 | +50.5% | 119,526 | +24.3% | 0.02% | +21.1% |
Q2 2022 | $434,000 | +101.9% | 96,131 | +230.3% | 0.02% | +90.0% |
Q1 2022 | $215,000 | -84.9% | 29,108 | -86.8% | 0.01% | -88.6% |
Q4 2021 | $1,420,000 | +573.0% | 220,875 | +510.1% | 0.09% | +417.6% |
Q3 2021 | $211,000 | -16.6% | 36,201 | +47.5% | 0.02% | -19.0% |
Q2 2021 | $253,000 | -29.5% | 24,542 | -28.1% | 0.02% | -36.4% |
Q1 2021 | $359,000 | -36.2% | 34,151 | -6.2% | 0.03% | -45.0% |
Q4 2020 | $563,000 | -30.3% | 36,400 | -14.6% | 0.06% | +7.1% |
Q2 2020 | $808,000 | +700.0% | 42,639 | +152.2% | 0.06% | +522.2% |
Q2 2019 | $101,000 | -30.8% | 16,907 | -32.3% | 0.01% | -10.0% |
Q1 2019 | $146,000 | -27.0% | 24,987 | +112.8% | 0.01% | -28.6% |
Q2 2018 | $200,000 | -51.9% | 11,743 | -62.1% | 0.01% | -51.7% |
Q1 2018 | $416,000 | +105.9% | 31,017 | +38.8% | 0.03% | -47.3% |
Q2 2017 | $202,000 | -26.0% | 22,348 | -23.0% | 0.06% | +27.9% |
Q4 2016 | $273,000 | -48.4% | 29,007 | -27.3% | 0.04% | -8.5% |
Q4 2015 | $529,000 | – | 39,900 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |